Introduction. The Herpesviruses (HHVs) are ubiquitous viral pathogens that cause significant morbidity and mortality immunodeficient patients. The persistence of these viruses has been described in several tissues including stomach, intestine and colon. It is known that viral reactivation from such reservoirs may induce disease in immunocompromised individuals. Then, in this study the presence of EBV, HHV6 and CMV was investigated in HIV1- positive patients. Methods. EBV, HHV6 and CMV DNA quantification was undertaken on 26 gastrointestinal biopsy samples (stomach, duodenum or colon) from 18 HIV-positive (HIV+) patients. The same viruses were also evaluated on 16 gastro-duodenal and colon biopsy specimens from 12 HIV-negative (HIV -) patients with gastrointestinal symptoms. Extracted DNA was analyzed for the presence of HHVs by TaqMan real time PCR using current criteria. Results. Viral-DNA was found in 17/18 (94%) HIV+ and in 8/12 (66%) HIV- patients (p=0.003). EBV-DNA was detected in

Introduction. The Herpesviruses (HHVs) are ubiquitous viral pathogens that cause significant morbidity and mortality immunodeficient patients. The persistence of these viruses has been described in several tissues including stomach, intestine and colon. It is known that viral reactivation from such reservoirs may induce disease in immunocompromised individuals. Then, in this study the presence of EBV, HHV6 and CMV was investigated in HIV1- positive patients. Methods. EBV, HHV6 and CMV DNA quantification was undertaken on 26 gastrointestinal biopsy samples (stomach, duodenum or colon) from 18 HIV-positive (HIV+) patients. The same viruses were also evaluated on 16 gastro-duodenal and colon biopsy specimens from 12 HIV-negative (HIV -) patients with gastrointestinal symptoms. Extracted DNA was analyzed for the presence of HHVs by TaqMan real time PCR using current criteria. Results. Viral-DNA was found in 17/18 (94%) HIV+ and in 8/12 (66%) HIV- patients (p=0.003). EBV-DNA was detected in: 6/9 gastric biopsies from HIV+ and in 4/10 from HIV(-) subjects (p=0.242); in 5/8 duodenal biopsies from HIV+ and in 1/4 from HIV- individuals (p=0.273); in 6/9 colon biopsies from HIV+ and in 0/2 from HIV- individuals (p=0.182). HHV6-DNA was detected in: 6/9 gastric biopsies from HIV+ and in 1/10 from HIV- subjects (p=0.017); in 6/8 duodenal biopsies from HIV+ and in 1/4 from HIV- patients (p=0.152); in 6/9 colon biopsies from HIV(+) and in 2/2 from HIV seronegative (p=0.509). The EBV/HHV6 coinfection was detected in 10/18 HIV+ while no coinfection was observed in HIV seronegative individuals (p=0.003). We never found CMV-DNA in both analysed group of patients. Conclusions. These results suggest that HHVs such as EBV and HHV6 can persist more frequently in the gastrointestinal mucosa of HIV + patients. The immunosuppresed state, due to HIV1-infection, might contribute both to the persistent of these viruses in gastrointestinal compartment and to the systemic reactivation.

EBV, HHV6 AND CMV DNA DETECTION IN GASTROINTESTINAL BIOPSIES FROM HIV-1 POSITIVE PATIENTS / Gaeta, Aurelia; Maida, Paola; Falasca, Francesca; Donato, Giuseppe; De Biase, E.; Fantauzzi, Alessandra; Nazzari, Cristina; Mezzaroma, Ivano; Turriziani, Ombretta; Antonelli, Guido. - ELETTRONICO. - (2012). ((Intervento presentato al convegno XLI Congresso Nazionale AMCLI tenutosi a Rimini nel 13-16 Novembre 2012.

EBV, HHV6 AND CMV DNA DETECTION IN GASTROINTESTINAL BIOPSIES FROM HIV-1 POSITIVE PATIENTS

GAETA, Aurelia;MAIDA, PAOLA;FALASCA, FRANCESCA;DONATO, Giuseppe;FANTAUZZI, Alessandra;NAZZARI, Cristina;MEZZAROMA, Ivano;TURRIZIANI, Ombretta;ANTONELLI, Guido
2012

Abstract

Introduction. The Herpesviruses (HHVs) are ubiquitous viral pathogens that cause significant morbidity and mortality immunodeficient patients. The persistence of these viruses has been described in several tissues including stomach, intestine and colon. It is known that viral reactivation from such reservoirs may induce disease in immunocompromised individuals. Then, in this study the presence of EBV, HHV6 and CMV was investigated in HIV1- positive patients. Methods. EBV, HHV6 and CMV DNA quantification was undertaken on 26 gastrointestinal biopsy samples (stomach, duodenum or colon) from 18 HIV-positive (HIV+) patients. The same viruses were also evaluated on 16 gastro-duodenal and colon biopsy specimens from 12 HIV-negative (HIV -) patients with gastrointestinal symptoms. Extracted DNA was analyzed for the presence of HHVs by TaqMan real time PCR using current criteria. Results. Viral-DNA was found in 17/18 (94%) HIV+ and in 8/12 (66%) HIV- patients (p=0.003). EBV-DNA was detected in: 6/9 gastric biopsies from HIV+ and in 4/10 from HIV(-) subjects (p=0.242); in 5/8 duodenal biopsies from HIV+ and in 1/4 from HIV- individuals (p=0.273); in 6/9 colon biopsies from HIV+ and in 0/2 from HIV- individuals (p=0.182). HHV6-DNA was detected in: 6/9 gastric biopsies from HIV+ and in 1/10 from HIV- subjects (p=0.017); in 6/8 duodenal biopsies from HIV+ and in 1/4 from HIV- patients (p=0.152); in 6/9 colon biopsies from HIV(+) and in 2/2 from HIV seronegative (p=0.509). The EBV/HHV6 coinfection was detected in 10/18 HIV+ while no coinfection was observed in HIV seronegative individuals (p=0.003). We never found CMV-DNA in both analysed group of patients. Conclusions. These results suggest that HHVs such as EBV and HHV6 can persist more frequently in the gastrointestinal mucosa of HIV + patients. The immunosuppresed state, due to HIV1-infection, might contribute both to the persistent of these viruses in gastrointestinal compartment and to the systemic reactivation.
Introduction. The Herpesviruses (HHVs) are ubiquitous viral pathogens that cause significant morbidity and mortality immunodeficient patients. The persistence of these viruses has been described in several tissues including stomach, intestine and colon. It is known that viral reactivation from such reservoirs may induce disease in immunocompromised individuals. Then, in this study the presence of EBV, HHV6 and CMV was investigated in HIV1- positive patients. Methods. EBV, HHV6 and CMV DNA quantification was undertaken on 26 gastrointestinal biopsy samples (stomach, duodenum or colon) from 18 HIV-positive (HIV+) patients. The same viruses were also evaluated on 16 gastro-duodenal and colon biopsy specimens from 12 HIV-negative (HIV -) patients with gastrointestinal symptoms. Extracted DNA was analyzed for the presence of HHVs by TaqMan real time PCR using current criteria. Results. Viral-DNA was found in 17/18 (94%) HIV+ and in 8/12 (66%) HIV- patients (p=0.003). EBV-DNA was detected in
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/630428
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact